The Access Consortium – founded in 2007 by regulatory authorities from Australia, Canada, Singapore, Switzerland, and recently joined also by UK’s MHRA – published a Statement to affirm the reliance of its members on GMP inspections carried out by other members of the consortium. The final goal is to mutually accept the results of inspections, so to avoid duplication of efforts. Inspections reports and other documentary evidence for GMP inspections conducted by members within their territory will be reviewed by other members to assess their reliability, even if the statement is not intend to create any legal obligation. Reduction of the regulatory burden and maximisation of the collaboration of the adhering agencies throughout the product lifecycle are the expected outcomes. The Access Consortium is also a Participating Authorities of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).